Vertex Planning Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.98M | Buy |
16,041
+23
| +0.1% | +$4.27K | 0.62% | 37 |
|
|
2025
Q1 | $3.36M | Buy |
16,018
+77
| +0.5% | +$16.1K | 0.73% | 29 |
|
|
2024
Q4 | $2.83M | Buy |
15,941
+5,721
| +56% | +$1.02M | 0.63% | 33 |
|
|
2024
Q3 | $2.02M | Buy |
10,220
+18
| +0.2% | +$3.56K | 0.48% | 34 |
|
|
2024
Q2 | $1.75M | Sell |
10,202
-82
| -0.8% | -$14.1K | 0.45% | 34 |
|
|
2024
Q1 | $1.87M | Sell |
10,284
-3,541
| -26% | -$645K | 0.52% | 30 |
|
|
2023
Q4 | $2.14M | Buy |
13,825
+3,032
| +28% | +$470K | 0.63% | 21 |
|
|
2023
Q3 | $1.61M | Buy |
10,793
+513
| +5% | +$76.5K | 0.55% | 24 |
|
|
2023
Q2 | $1.39M | Buy |
10,280
+5,320
| +107% | +$717K | 0.47% | 35 |
|
|
2023
Q1 | $790K | Sell |
4,960
-1,742
| -26% | -$278K | 0.3% | 48 |
|
|
2022
Q4 | $1.08M | Buy |
+6,702
| New | +$1.08M | 0.42% | 31 |
|